Filing Details

Accession Number:
0001144204-10-019117
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-08 13:00:00
Reporting Period:
2010-03-31
Filing Date:
2010-04-08
Accepted Time:
2010-04-08 15:11:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
892160 Derma Sciences Inc. DSCI Surgical & Medical Instruments & Apparatus (3841) 232328753
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1483051 Brett Hewlett Wilson Road South
Private Bag 1
Te Puke Q2 3189
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-31 858,333 $0.00 0 No 4 S Indirect By Comvita New Zealand Limited
Common Stock Acquisiton 2010-03-31 858,333 $0.00 858,333 No 4 P Indirect By Comvita Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Comvita New Zealand Limited
No 4 P Indirect By Comvita Limited
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series Q Warrants Disposition 2010-03-31 133,333 $0.00 133,333 $5.50
Common Stock Series N Warrants Disposition 2010-03-31 100,000 $0.00 100,000 $6.25
Common Stock Series H Warrants Disposition 2010-03-31 52,084 $0.00 52,084 $8.00
Common Stock Series Q Warrants Acquisiton 2010-03-31 133,333 $0.00 133,333 $5.50
Common Stock Series N Warrants Acquisiton 2010-03-31 100,000 $0.00 100,000 $6.25
Common Stock Series H Warrants Acquisiton 2010-03-31 52,084 $0.00 52,084 $8.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-23 2015-02-23 No 4 S Indirect
0 2010-02-23 2015-02-23 No 4 S Indirect
0 2006-04-18 2011-04-30 No 4 S Indirect
133,333 2010-02-23 2015-02-23 No 4 P Indirect
100,000 2010-02-23 2015-02-23 No 4 P Indirect
52,084 2006-04-18 2011-04-30 No 4 P Indirect
Footnotes
  1. The securities reported herein were originally issued to Comvita New Zealand Limited. Comvita New Zealand Limited is a wholly-owned subsidiary of Comvita Limited, the parent corporation. The securities reported herein were subsequently distributed by Comvita New Zealand Limited to Comvita Limited without payment of cash consideration. The distribution from Comvita New Zealand Limited to Comvita Limited effected a change in the form of beneficial ownership exempt under Rule 16a-13.
  2. The securities reported herein were previously held by Comvita New Zealand Limited. Brett Hewlett is the Chief Executive Officer of Comvita New Zealand Limited and therefore may be deemed to have shared voting and investment power with respect to these securities previously held by Comvita New Zealand Limited. Mr. Hewlett disclaimed beneficial ownership of these securities previously held by Comvita New Zealand Limited.
  3. The securities reported herein are held by Comvita Limited. Brett Hewlett is the Chief Executive Officer of Comvita Limited and therefore may be deemed to share voting and investment power with respect to these securities held by Comvita Limited. Mr. Hewlett disclaims beneficial ownership of these securities held by Comvita Limited.